Glenmark Pharmaceuticals informs about media release

23 Aug 2019

Glenmark Pharmaceuticals has informed about media release titled: ‘Glenmark Pharmaceuticals receives ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL)’.

The above information is a part of company’s filings submitted to BSE.

Related Glenmark Pharmaceuticals Ltd. Links:

Glenmark Pharma Share Price

479.00 2.80 (0.59%) Mar 03, 18:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 624.15
Dr. Reddys Lab 4500.80
Lupin 1060.85
Piramal Enterprises 1992.70
Cadila Healthcare 445.50
View more..
Sensex vs Glenmark Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback